World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
53
Citations
9635
World Ranking
16216
National Ranking
6719

Chemistry

D-Index
49
Citations
9133
World Ranking
14774
National Ranking
3772

Grzegorz Bulaj publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Grzegorz Bulaj sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 132 publications — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Grzegorz Bulaj D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Grzegorz Bulaj sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 49 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Grzegorz Bulaj is affiliated with the University of Utah in the United States. Their work primarily spans psychology and medicine, with a particular focus on subfields such as applied psychology, cellular and molecular neuroscience, clinical psychology, health, toxicology and mutagenesis, and general health professions.

The scientist's research extensively covers topics involving digital mental health interventions, urban green space and health, neuropeptides and animal physiology, mental health research topics, COVID-19 and mental health, mobile health and mHealth applications, as well as musculoskeletal pain and rehabilitation.

Frequent publication venues for their research include the International Journal of Environmental Research and Public Health, Healthcare, CNS Spectrums, Journal of Clinical Medicine, and Frontiers in Digital Health.

Recent papers authored or coauthored by Grzegorz Bulaj include:

  • Healthy Dwelling: Design of Biophilic Interior Environments Fostering Self-Care Practices for People Living with Migraines, Chronic Pain, and Depression, 2022, International Journal of Environmental Research and Public Health
  • Digital health technologies and major depressive disorder, 2023, CNS Spectrums
  • Digital Therapeutics for Improving Effectiveness of Pharmaceutical Drugs and Biological Products: Preclinical and Clinical Studies Supporting Development of Drug + Digital Combination Therapies for Chronic Diseases, 2024, Journal of Clinical Medicine
  • Adjunct Digital Interventions Improve Opioid-Based Pain Management: Impact of Virtual Reality and Mobile Applications on Patient-Centered Pharmacy Care, 2022, Frontiers in Digital Health
  • Digital Therapeutics (DTx) Expand Multimodal Treatment Options for Chronic Low Back Pain: The Nexus of Precision Medicine, Patient Education, and Public Health, 2023, Healthcare

Grzegorz Bulaj frequently collaborates with several researchers, including Dorothy Day Huntsman, Aarushi Rohaj, Zack Biskupiak, Aleksandra Walewska, and Paulina Kosikowska. These partnerships reflect consistent collaboration within fields related to mental health and digital therapeutics research.

Best Publications

  • Ribosomally synthesized and post-translationally modified peptide natural products: Overview and recommendations for a universal nomenclature

    Paul G. Arnison;Mervyn J. Bibb;Gabriele Bierbaum;Albert Alexander Bowers

  • Ionization−Reactivity Relationships for Cysteine Thiols in Polypeptides†

    Grzegorz Bulaj;Tanja Kortemme;David P. Goldenberg

  • Formation of disulfide bonds in proteins and peptides

    Grzegorz Bulaj

  • Conotoxins and the posttranslational modification of secreted gene products.

    O. Buczek;G. Bulaj;B. M. Olivera

  • Conus Venoms : A Rich Source of Peptide-Based Therapeutics

    Tiffany S. Han;Russell W. Teichert;Baldomero M. Olivera;Grzegorz Bulaj

  • Converting Peptides into Drug Leads by Lipidation

    L. Zhang;G. Bulaj

  • Structure/Function Characterization of μ-Conotoxin KIIIA, an Analgesic, Nearly Irreversible Blocker of Mammalian Neuronal Sodium Channels

    Min Min Zhang;Brad R. Green;Philip Catlin;Brian Fiedler

  • Conotoxins-New Vistas for Peptide Therapeutics

    Robert Jones;Grzegorz Bulaj

  • μ-Conotoxins that differentially block sodium channels NaV1.1 through 1.8 identify those responsible for action potentials in sciatic nerve

    Michael J. Wilson;Doju Yoshikami;Layla Azam;Joanna Gajewiak

  • Novel conotoxins from Conus striatus and Conus kinoshitai selectively block TTX-resistant sodium channels.

    Grzegorz. Bulaj;Peter J. West;James E. Garrett;Maren. Watkins

  • Isolation and characterization of a novel conus peptide with apparent antinociceptive activity.

    J M McIntosh;G O Corpuz;R T Layer;J E Garrett

  • Folding of conotoxins: formation of the native disulfide bridges during chemical synthesis and biosynthesis of Conus peptides.

    Grzegorz Bulaj;Baldomero M. Olivera

  • Circular Logic: Nonribosomal Peptide-like Macrocyclization with a Ribosomal Peptide Catalyst

    John A. McIntosh;Charles R. Robertson;Vinayak Agarwal;Satish K. Nair

  • Efficient oxidative folding of conotoxins and the radiation of venomous cone snails.

    Grzegorz Bulaj;Olga Buczek;Ian Goodsell;Elsie C. Jimenez;Elsie C. Jimenez

  • μ-Conotoxin SmIIIA, a Potent Inhibitor of Tetrodotoxin-Resistant Sodium Channels in Amphibian Sympathetic and Sensory Neurons†

    Peter J. West;Grzegorz Bulaj;James E. Garrett;Baldomero M. Olivera

  • Post-translational Amino Acid Isomerization A FUNCTIONALLY IMPORTANT d-AMINO ACID IN AN EXCITATORY PEPTIDE

    Olga Buczek;Doju Yoshikami;Grzegorz Bulaj;Elsie C. Jimenez;Elsie C. Jimenez

  • Synthetic μO-conotoxin MrVIB blocks TTX-resistant sodium channel Nav1.8 and has a long-lasting analgesic activity

    Grzegorz Bulaj;Min Min Zhang;Brad R. Green;Brian Fiedler

  • Conotoxins Containing Nonnatural Backbone Spacers: Cladistic-Based Design, Chemical Synthesis, and Improved Analgesic Activity

    Brad R. Green;Philip Catlin;Min Min Zhang;Brian Fiedler

  • Neuroprotective and cardioprotective conopeptides: an emerging class of drug leads.

    Vernon D Twede;George Miljanich;Baldomero M Olivera;Grzegorz Bulaj

  • Delta-conotoxin structure/function through a cladistic analysis.

    Grzegorz Bulaj;Richard DeLaCruz;Aryan Azimi-Zonooz;Peter West

Frequent Co-Authors

Baldomero M. Olivera
Baldomero M. Olivera University of Utah
Doju Yoshikami
Doju Yoshikami University of Utah
H. Steve White
H. Steve White University of Washington
Raymond S. Norton
Raymond S. Norton Monash University
Brian J. Smith
Brian J. Smith QIMR Berghofer Medical Research Institute
David M. Goldenberg
David M. Goldenberg Immunomedics (United States)
Jean Rivier
Jean Rivier Salk Institute for Biological Studies
Eric W. Schmidt
Eric W. Schmidt University of Utah
Satish K. Nair
Satish K. Nair University of Illinois at Urbana-Champaign
J. Michael McIntosh
J. Michael McIntosh University of Utah

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to diverse career opportunities across various industries. For those exploring legal aspects related to chemical patents or regulations, pursuing degrees for paralegals can provide valuable skills to support law firms or corporate legal teams.

The pharmaceutical sector is a prominent field where chemistry graduates thrive. Becoming a pharmaceutical sales representative is a common pathway, and understanding the pharma sales rep salary landscape helps in evaluating potential earnings and career growth.

For those passionate about healthcare and medication development, advancing to be a pharmacist involves specialized training. Learning about how long does it take to become a pharmacist can help plan your educational journey effectively.

Additionally, chemistry knowledge is essential in forensic science careers such as an autopsy technician. Understanding the requirements for autopsy technician school can guide aspiring professionals toward entering this critical field.

Best Scientists Citing Grzegorz Bulaj

Trending Scientists